Literature DB >> 9380063

Severe constipation in Parkinson's disease relieved by botulinum toxin.

A Albanese1, G Maria, A R Bentivoglio, G Brisinda, E Cassetta, P Tonali.   

Abstract

A parkinsonian patient with severe outlet-type constipation was treated with injection of botulinum toxin into the puborectalis muscle. A total of 30 units (Botox) was injected in two sites. Resting anal pressure, maximum voluntary contraction, and pressure on straining were evaluated before treatment and 4, 8, 12, and 16 weeks afterward. Pressure values declined following treatment, the decline of pressure on straining ending by week 12. Proctography performed 8 weeks after treatment showed improvement in the anorectal angle and evacuation of barium paste. The clinical benefit lasted for approximately 12 weeks. The present data show that botulinum toxin is a promising tool for treating outlet-type constipation in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9380063     DOI: 10.1002/mds.870120524

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

Review 1.  Botulinum toxin in clinical practice.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

Review 2.  Gastrointestinal features of Parkinson's disease.

Authors:  Leslie J Cloud; James G Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

3.  Botulinum toxin type-A injection to treat patients with intractable anismus unresponsive to simple biofeedback training.

Authors:  Yong Zhang; Zhen-Ning Wang; Lei He; Ge Gao; Qing Zhai; Zhi-Tao Yin; Xian-Dong Zeng
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 4.  Intractable Constipation in the Elderly.

Authors:  Noemi Baffy; Amy E Foxx-Orenstein; Lucinda A Harris; Susan Sterler
Journal:  Curr Treat Options Gastroenterol       Date:  2017-09

5.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

Review 6.  Management of bladder, prostatic and pelvic floor disorders.

Authors:  G Brisinda; G Maria; A R Bentivoglio; F Cadeddu; G Marniga; F Brandara; A Albanese
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 7.  Botulinum toxin for gastrointestinal disorders: therapy and mechanisms.

Authors:  H Vittal; P F Pasricha
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 8.  [Gastrointestinal dysfunction in idiopathic Parkinson's disease].

Authors:  K Del Tredici; W H Jost
Journal:  Nervenarzt       Date:  2012-10       Impact factor: 1.214

9.  Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dosage regimens.

Authors:  G Maria; G Brisinda; A R Bentivoglio; E Cassetta; D Gui; A Albanese
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

Review 10.  Gastrointestinal dysfunction in the synucleinopathies.

Authors:  Kathryn A Chung; Ronald F Pfeiffer
Journal:  Clin Auton Res       Date:  2020-11-27       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.